[1]
Wollenberg, A., Guttman-Yassky, E., Torpet, M. and Silverberg, J.I. 2018. Risk of anaphylaxis and conjunctivitis with tralokinumab in atopic dermatitis. SKIN The Journal of Cutaneous Medicine. 2, (Dec. 2018), S63. DOI:https://doi.org/10.25251/skin.2.supp.63.